Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Yan Yu's publication output changed over time?
ScholarIQpublication output · 2015–2024
Output declined50% over the shown period — from 2 works in 2015 to 1 in 2024.
2
2
1
2
1
2
1
2015201720202021202220232024
What are the most-cited papers on Yan Yu?
ScholarIQmost cited works
Osimertinib with or without Chemotherapy in <i>EGFR</i> -Mutated Advanced NSCLC
David Planchard, Pasi A. Jänne, Ying Cheng, James Chih‐Hsin Yang, Noriko Yanagitani, Sang‐We Kim, Shunichi Sugawara, Yan Yu, Yun Fan, Sarayut Lucien Geater, К. К. Лактионов, Chee Khoon Lee, Natalia Valdiviezo, Samreen Ahmed, Jean-Marc Maurel, Igor Andrašina, Jonathan W. Goldman, Dana Ghiorghiu, Yuri Rukazenkov, Alex Todd, Kunihiko Kobayashi
New England Journal of Medicine. 2023690 CitationsOPEN ACCESS
Regulation of glycolytic metabolism by autophagy in liver cancer involves selective autophagic degradation of HK2 (hexokinase 2)
Lin Jiao, Hai‐Liang Zhang, Dandan Li, Ke-Li Yang, Jun Tang, Xuan Li, Jiao Ji, Yan Yu, Rui-Yan Wu, Ravichandran Senthilkumar, Jianjun Liu, Gong-Kan Feng, Min-Shan Chen, Yi-Xin Zeng, Rong Deng, Xiao‐Feng Zhu
S102544370. 2017281 CitationsOPEN ACCESS
Acetylation of Beclin 1 inhibits autophagosome maturation and promotes tumour growth
Ting Sun, Xuan Li, Peng Zhang, Wen-Dan Chen, Hai‐Liang Zhang, Dandan Li, Rong Deng, Xiao-Jun Qian, Lin Jiao, Jiao Ji, Yun-Tian Li, Rui-Yan Wu, Yan Yu, Gong-Kan Feng, Xiao‐Feng Zhu
Nature Communications. 2015225 CitationsOPEN ACCESS
CUL3 (cullin 3)-mediated ubiquitination and degradation of BECN1 (beclin 1) inhibit autophagy and promote tumor progression
Xuan Li, Kai‐Bin Yang, Wei Chen, Jia Mai, Xiao-Qi Wu, Ting Sun, Ruiyan Wu, Lin Jiao, Dandan Li, Jiao Ji, Hai‐Liang Zhang, Yan Yu, Yuhong Chen, Gong‐Kan Feng, Rong Deng, Jun‐Dong Li, Xiao‐Feng Zhu
S102544370. 2021218 CitationsOPEN ACCESS
Toripalimab Plus Chemotherapy for Patients With Treatment-Naive Advanced Non–Small-Cell Lung Cancer: A Multicenter Randomized Phase III Trial (CHOICE-01)
Zhijie Wang, Lin Wu, Baolan Li, Ying Cheng, Xiaoling Li, Xicheng Wang, Liang Han, Xiaohong Wu, Yun Fan, Yan Yu, Dongqing Lv, Jianhua Shi, Jianjin Huang, Shaozhang Zhou, Baohui Han, Guogui Sun, Qisen Guo, Youxin Ji, Xiaoli Zhu, Sheng Hu, Wei Zhang, Qiming Wang, Yuming Jia, Ziping Wang, Yong Song, Jingxun Wu, Meiqi Shi, Xingya Li, Zhigang Han, Yunpeng Liu, Zhuang Yu, Anwen Liu, Xiuwen Wang, Caicun Zhou, Diansheng Zhong, Liyun Miao, Zhihong Zhang, Hui Zhao, Jiaqi Yang, Dong Wang, Yingyi Wang, Qiang Li, Xiaodong Zhang, Mei Ji, Zhenzhou Yang, Jiuwei Cui, Beili Gao, Buhai Wang, Hu Liu, Lei Nie, Mei He, Jin Shi, Wei Gu, Yongqian Shu, Tong Zhou, Jian Feng, Xinmei Yang, Cheng Huang, Bo Zhu, Yu Yao, Xiongwen Tang, Jianjun Yu, Ellen Maher, Hui Feng, Sheng Yao, Patricia Keegan, Jie Wang
Journal of Clinical Oncology. 2022177 CitationsOPEN ACCESS
Related on ScholarIQ
Harbin Medical University
Institution
Osimertinib with or without Chemotherapy in <i>EGFR</i> -Mutated Advanced NSCLC
Paper
Regulation of glycolytic metabolism by autophagy in liver cancer involves selective autophagic degradation of HK2 (hexokinase 2)
Paper
Acetylation of Beclin 1 inhibits autophagosome maturation and promotes tumour growth
Paper
CUL3 (cullin 3)-mediated ubiquitination and degradation of BECN1 (beclin 1) inhibit autophagy and promote tumor progression
Paper
Toripalimab Plus Chemotherapy for Patients With Treatment-Naive Advanced Non–Small-Cell Lung Cancer: A Multicenter Randomized Phase III Trial (CHOICE-01)
Paper